The Global Asthma and COPD Market was valued at US$ 39,021.2 Mn in 2016 and is expected to reach US$ 56,507.7 Mn by 2027, expanding at a CAGR of 4% from 2021 to 2027. Asthma is a chronic respiratory disease that blocks the airways of the lungs due to inflammation, mucus production, and muscle strengthening. […]
